SHERISSA-NICOLE SEBASTIAN: Open Payments
NPI 1487313698 · WESTMINSTER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$123 in 7 payments from 6 companies in 2025. Trend: 2023 $971 · 2024 $149 · 2025 $123
Food & beverage: $123
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 1 | $26 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| Corium, LLC | 2 | $14 |
Products named: VRAYLAR, INGREZZA, CAPLYTA, KISUNLA, Jornay PM, Azstarys.
Industry payments across CO — which companies pay providers there.
